Keyphrases
Acute Myeloid Leukemia
100%
Histone Deacetylases
100%
Expression Pattern
100%
Deacetylase Inhibitor
100%
Histone Deacetylase Inhibitor (HDACi)
83%
CD34+
33%
SIRT4
33%
Clinical Development
16%
Butyrate
16%
Histone Acetylation
16%
Lysine
16%
Control Cell
16%
Histone Deacetylase 6 (HDAC6)
16%
Histone Deacetylase 1 (HDAC1)
16%
Myeloid Cells
16%
Drug Resistance
16%
Distinct Patterns
16%
Hypermethylation
16%
Clinical Response
16%
Therapeutic Strategies
16%
Peripheral Blood Mononuclear Cells
16%
Drug Class
16%
Disease-specific
16%
Disease Mechanisms
16%
Umbilical Cord
16%
Inhibitor Activity
16%
Valproate
16%
Antileukemic Activity
16%
Histone Deacetylase 9 (HDAC9)
16%
HDAC11
16%
Histone Deacetylase 5 (HDAC5)
16%
Sirtuin 1 (SIRT1)
16%
Donor Blood
16%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Histone Deacetylase
100%
Histone Deacetylase Inhibitor
83%
Cell Line
16%
Drug Resistance
16%
Peripheral Blood Mononuclear Cell
16%
Umbilical Cord
16%
Histone
16%
Sodium Valproate
16%
Myeloid Cell
16%
Histone Deacetylase 11
16%
Histone Deacetylase 5
16%
Histone Deacetylase 9
16%
Vorinostat
16%
Histone Deacetylase 6
16%
Butyric Acid
16%
Lysine
16%
Sirtuin1
16%
Diseases
16%
Neuroscience
Histone Deacetylase
100%
Myeloid
100%
Histone Deacetylase Inhibitor
71%
CD34
28%
Cell Line
14%
Lysine
14%
Histone
14%
Butyric Acid
14%
Drug Resistance
14%
Butyrate
14%
Histone Deacetylase 5
14%
Peripheral Blood Mononuclear Cell
14%
Histone Deacetylase 9
14%
Histone Deacetylase 6
14%
Histone Deacetylase 11
14%
Biochemistry, Genetics and Molecular Biology
Histone Deacetylase
100%
Myeloid
100%
CD34
28%
SIRT4
28%
Lysine
14%
HDAC6
14%
Histone
14%
Butyrate
14%
Peripheral Blood Mononuclear Cell
14%
Drug Resistance
14%
HDAC9
14%
Sirtuin1
14%
HDAC11
14%
Histone Deacetylase 5
14%
Immunology and Microbiology
Myeloid
100%
Histone
100%
CD34
25%
Cell Line
12%
Drug Resistance
12%
Peripheral Blood Mononuclear Cell
12%
Umbilical Cord
12%
Lysine
12%